Shannon Entropy of Gray Matter Eigenmodes: A Novel Biomarker for Alzheimer's Disease and Heterogeneous MCI Trajectories
Advanced Science · 2026
DOI: 10.1002/advs.202511614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yumeng Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Aging Brain Rejuvenation Initiative (BABRI) Centre, Beijing Normal University, Beijing, 100875, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Gray Matter, Cognitive Dysfunction. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STI2030-Major Projects, National Natural Science Foundation of China, State Key Program of National Natural Science of China.
Themen: Demenz
Abstract (Originalsprache)
Current Alzheimer's disease (AD) diagnostics rely on late‐stage cognitive assessments or invasive biomarkers. Neuroimaging offers non‐invasive alternatives, but single‐modality approaches (structural atrophy or functional connectivity) face limitations in sensitivity and specificity for early detection. Entropy and temperature, novel structure‐function coupling (SFC) biomarkers based on gray matter eigenmodes, are introduced to quantify cortical disorganization in early AD. Using multimodal MRI and amyloid‐PET data from two cohorts (BABRI: N = 135; ADNI: N = 275), including cognitively normal (CN), mild cognitive impairment (MCI), and AD individuals, entropy is computed by projecting fMRI onto structural eigenmodes and temperature via eigenmode‐based functional connectivity reconstruction. These indices are tested for diagnostic classification, Aβ prediction, and MCI subtype stratification (reversed/stable/progressed). Entropy is significantly higher in AD than CN and MCI (Δ = 8–21%, p < 0.001) in both cohorts. Left‐hemisphere entropy yielded optimal diagnostic accuracy (AUC = 0.901 for CN vs MCI), while right/global entropy predicted Aβ burden (error reduction: 38.7–42.1%, p < 0.01). Entropy also distinguished MCI subtypes and captured biphasic changes in progressors. Temperature indices showed no significant group differences. Entropy from gray matter eigenmodes is a sensitive, non‐invasive biomarker for AD diagnosis and pathology prediction, revealing hemispheric asymmetries and nonlinear progression in MCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Aging Brain Rejuvenation Initiative (BABRI) Centre, Beijing Normal University, Beijing, 100875, China.
- State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, 100875, China.
- College of Physics & Optoelectronic Engineering, Jinan University, Guangzhou, 510632, China.
- Banner Alzheimer's Institute, Phoenix, AZ, 85006, USA.
ORCID-Profile: Yumeng Li, Gaoping Long, Xin Li
Förderung
- STI2030-Major Projects
- National Natural Science Foundation of China
- State Key Program of National Natural Science of China
- Fundamental Research Funds for the Central Public welfare research institution
Zitieren
APA
Li, Y., Long, G., Zhang, X., Chen, K., Li, X., & Zhang, Z. (2026). Shannon Entropy of Gray Matter Eigenmodes: A Novel Biomarker for Alzheimer's Disease and Heterogeneous MCI Trajectories. Advanced Science. https://doi.org/10.1002/advs.202511614
Vancouver
Li Y, Long G, Zhang X, Chen K, Li X, Zhang Z. Shannon Entropy of Gray Matter Eigenmodes: A Novel Biomarker for Alzheimer's Disease and Heterogeneous MCI Trajectories. Advanced Science. 2026. doi:10.1002/advs.202511614
BibTeX
@article{Li2026,
author = {Li, Yumeng and Long, Gaoping and Zhang, Xinyue and Chen, Kewei and Li, Xin and Zhang, Zhanjun},
title = {Shannon Entropy of Gray Matter Eigenmodes: A Novel Biomarker for Alzheimer's Disease and Heterogeneous MCI Trajectories},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202511614}
}
EUVIMED